Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties

Luca Gallelli1,2 1Department of Health Science, School of Medicine, University of Catanzaro, Catanzaro, Italy; 2Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Catanzaro, ItalyCorrespondence: Luca GallelliOperative Unit of Clinical Pharmacology and Ph...

Full description

Bibliographic Details
Main Author: Gallelli L
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/escin-a-review-of-its-anti-edematous-anti-inflammatory-and-venotonic-p-peer-reviewed-article-DDDT
id doaj-29ffa8915bd94738b9bf0af1187b1345
record_format Article
spelling doaj-29ffa8915bd94738b9bf0af1187b13452020-11-25T02:39:33ZengDove Medical PressDrug Design, Development and Therapy1177-88812019-09-01Volume 133425343748856Escin: a review of its anti-edematous, anti-inflammatory, and venotonic propertiesGallelli LLuca Gallelli1,2 1Department of Health Science, School of Medicine, University of Catanzaro, Catanzaro, Italy; 2Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Catanzaro, ItalyCorrespondence: Luca GallelliOperative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Viale Tommaso Campanella 115, Catanzaro 88100, ItalyTel +39 96 171 2322Fax +39 96 177 4424Email gallelli@unicz.itAbstract: This review discusses historical and recent pharmacological and clinical data on the anti-edematous, anti-inflammatory, and venotonic properties of escin (Reparil®). Escin, the active component of Aesculus hippocastanum, or horse chestnut, is available as orally absorbable dragées and as a transdermal gel. The anti-inflammatory and anti-edematous effects of escin have been studied over many years in pre-clinical models. More recent data confirm the anti-inflammatory properties of escin in reducing vascular permeability in inflamed tissues, thereby inhibiting edema formation. The venotonic effects of escin have been demonstrated primarily by in vitro studies of isolated human saphenous veins. The ability of escin to prevent hypoxia-induced disruption to the normal expression and distribution of platelet endothelial cell-adhesion molecule-1 may help explain its protective effect on blood vessel permeability. Escin oral dragées and transdermal gel have both demonstrated efficacy in blunt trauma injuries and in chronic venous insufficiency. Both oral escin and the transdermal gel are well tolerated.Keywords: blunt trauma, chronic venous insufficiency, edema, escin, pain, Reparil®https://www.dovepress.com/escin-a-review-of-its-anti-edematous-anti-inflammatory-and-venotonic-p-peer-reviewed-article-DDDTblunt traumachronic venous insufficiencyedemaescinpainReparil®
collection DOAJ
language English
format Article
sources DOAJ
author Gallelli L
spellingShingle Gallelli L
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
Drug Design, Development and Therapy
blunt trauma
chronic venous insufficiency
edema
escin
pain
Reparil®
author_facet Gallelli L
author_sort Gallelli L
title Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
title_short Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
title_full Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
title_fullStr Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
title_full_unstemmed Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
title_sort escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
publisher Dove Medical Press
series Drug Design, Development and Therapy
issn 1177-8881
publishDate 2019-09-01
description Luca Gallelli1,2 1Department of Health Science, School of Medicine, University of Catanzaro, Catanzaro, Italy; 2Operative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Catanzaro, ItalyCorrespondence: Luca GallelliOperative Unit of Clinical Pharmacology and Pharmacovigilance, Azienda Ospedaliera Mater Domini, Viale Tommaso Campanella 115, Catanzaro 88100, ItalyTel +39 96 171 2322Fax +39 96 177 4424Email gallelli@unicz.itAbstract: This review discusses historical and recent pharmacological and clinical data on the anti-edematous, anti-inflammatory, and venotonic properties of escin (Reparil®). Escin, the active component of Aesculus hippocastanum, or horse chestnut, is available as orally absorbable dragées and as a transdermal gel. The anti-inflammatory and anti-edematous effects of escin have been studied over many years in pre-clinical models. More recent data confirm the anti-inflammatory properties of escin in reducing vascular permeability in inflamed tissues, thereby inhibiting edema formation. The venotonic effects of escin have been demonstrated primarily by in vitro studies of isolated human saphenous veins. The ability of escin to prevent hypoxia-induced disruption to the normal expression and distribution of platelet endothelial cell-adhesion molecule-1 may help explain its protective effect on blood vessel permeability. Escin oral dragées and transdermal gel have both demonstrated efficacy in blunt trauma injuries and in chronic venous insufficiency. Both oral escin and the transdermal gel are well tolerated.Keywords: blunt trauma, chronic venous insufficiency, edema, escin, pain, Reparil®
topic blunt trauma
chronic venous insufficiency
edema
escin
pain
Reparil®
url https://www.dovepress.com/escin-a-review-of-its-anti-edematous-anti-inflammatory-and-venotonic-p-peer-reviewed-article-DDDT
work_keys_str_mv AT gallellil escinareviewofitsantiedematousantiinflammatoryandvenotonicproperties
_version_ 1724785428955922432